📈 🇨🇦 TSX Movers: Top Gainers & Losers (August 16th)

In partnership with

• The TSX rose 0.5% last week, bringing year-to-date gains to 12.9%, supported by resilient economic conditions despite trade disruptions.

• Canada’s inflation data due this week will be pivotal in shaping the Bank of Canada’s next move, with two additional rate cuts still possible as growth moderates and price pressures cool.

Big investors are buying this “unlisted” stock

When the founder who sold his last company to Zillow for $120M starts a new venture, people notice. That’s why the same VCs who backed Uber, Venmo, and eBay also invested in Pacaso.

Disrupting the real estate industry once again, Pacaso’s streamlined platform offers co-ownership of premier properties, revamping the $1.3T vacation home market.

And it works. By handing keys to 2,000+ happy homeowners, Pacaso has already made $110M+ in gross profits in their operating history.

Now, after 41% YoY gross profit growth last year alone, they recently reserved the Nasdaq ticker PCSO.

Invest for $2.90/Share

_{Paid advertisement for Pacaso’s Regulation A offering. Read the offering circular at invest.pacaso.com. Reserving a ticker symbol is not a guarantee that the company will go public. Listing on the NASDAQ is subject to approvals.}

Here's a summary of the top-performing and underperforming stocks on the Toronto Stock Exchange (TSX) over the past week:

📈 Top Gainers

The free newsletter making HR less lonely

The best HR advice comes from those in the trenches. That’s what this is: real-world HR insights delivered in a newsletter from Hebba Youssef, a Chief People Officer who’s been there. Practical, real strategies with a dash of humor. Because HR shouldn’t be thankless—and you shouldn’t be alone in it.

Sign Up Free

📉 Top Decliners

• Marimaca Copper Corp. announced new drilling results at its Pampa Medina deposit, extending the high-grade system 300m west of prior work. The site is near the company’s existing oxide deposit in Chile’s Atacama Desert. A 10,000m drilling program is underway with three rigs on site, and shares rose to $11.02 (+$1.11) on the news.

• Profound Medical’s Q2 2025 results were mixed: gross margin improved to 73% and the company advanced its pipeline with the fully recruited Captain trial and upcoming AI software launch. However, revenue missed expectations, losses widened to $15.7M, and expenses climbed sharply amid its transition to a capital sales model. Management remains optimistic about long-term growth with a targeted 70% recurring revenue mix and positive physician feedback on trial progress.

Real News for Real People — Not Partisans

Feeling like you want to get off the rollercoaster of polarizing politics? Read Tangle — an independent and nonpartisan political newsletter recently profiled on This American Life for helping to bridge the gap between politically divided families. Each day, the newsletter unpacks one important news story, examining it from all sides of the political spectrum.

Read it for free.